PDE9A and cardiac hypertrophy: In a murine model of chronic LV pressure overload, NP‐dependent cGMP‐PKG signaling attenuated myocardial hypertrophy and reversed LV dysfunction when PDE9A was inhibited (Lee et al., 2015).